Skip to main content
HR 3093 118th Congress House Health Government information and archives Health care costs and insurance Prescription drugs

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023

Introduced: May 26, 2023 Introduced by: Hoyle, Val T. Democratic · Oregon See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 12, 2023
Referred to the Subcommittee on Health.
May 5, 2023
Referred to the House Committee on Energy and Commerce.
May 5, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023

This bill requires companies that receive federal funding for research (or a license of the rights to a patent or regulatory test data) for a biomedical product or service to agree to set reasonable prices for the resulting biomedical product or service.

The Department of Health and Human Services (HHS) must determine a reasonable price based on a formula that ensures the U.S. price for the product or service is not more than the median price for the product or service in Canada and six other reference countries with, based on specified criteria, large economies and high incomes.

Companies entering these agreements also must report to HHS certain financial information related to the biomedical product or service involved.

What's happening now May 12, 2023

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 18
All 18 Democratic 17
D
Tlaib, Rashida
Michigan · Aug 4, 2023
 D
Magaziner, Seth
Rhode Island · Jun 13, 2023
 D
Takano, Mark
California · Jun 7, 2023
 D
Casar, Greg
Texas · May 26, 2023
 D
Cohen, Steve
Tennessee · May 5, 2023
 D
DeLauro, Rosa L.
Connecticut · May 5, 2023
 D
Doggett, Lloyd
Texas · May 5, 2023
 D
García, Jesús G. "Chuy"
Illinois · May 5, 2023
 D
Grijalva, Raúl M.
Arizona · May 5, 2023
 D
Jayapal, Pramila
Washington · May 5, 2023
 D
Kaptur, Marcy
Ohio · May 5, 2023
 D
Khanna, Ro
California · May 5, 2023
 D
Norton, Eleanor Holmes
District of Columbia · May 5, 2023
 D
Pingree, Chellie
Maine · May 5, 2023
 D
Pocan, Mark
Wisconsin · May 5, 2023
 D
Schakowsky, Janice D.
Illinois · May 5, 2023
 D
Stansbury, Melanie A.
New Mexico · May 5, 2023
 D
Tokuda, Jill N.
Hawaii · May 5, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3093: Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-3093/
MLA
"H.R. 3093: Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-3093/.
Bluebook (legal)
H.R. 3093, 118th Cong. (2026), https://openamerica.io/bill/118-HR-3093/.
Markdown link
[H.R. 3093: Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023](https://openamerica.io/bill/118-HR-3093/)
Report a problem